Article

Science & Innovation

Harnessing the Power of AI to Detect ATTR-CM

Artificial intelligence (AI) has quietly become a part of our daily lives – through personalized recommendations, virtual assistants, or smart devices, we barely notice it anymore. Yet many of us might not realize the advances AI is making in healthcare. From accelerating drug discovery to improving disease detection, it is transforming the way we understand and manage health.AI has had numerous applications in cardiology in recent years, from analyzing results of cardiac imaging tests to...

Pfizer’s Annual DEI Summit Focuses on Inclusion and Connection

Earlier this fall, Pfizer held our annual all-company DEI summit, which was created years ago in an effort to bring colleagues together to discuss important topics around diversity, equity, and inclusion.This year’s Summit, hosted by Chief Global DEI Officer Ramcess Jean-Louis, was themed “Anchor in Trust, Connection Matters” and focused on creating an inclusive environment for all colleagues through representation and building meaningful connections grounded in trust. (Last year’s summit focuse...

November Social Media Round-Up—Access to Medicine Foundation Index, Fortune’s 100 Most Powerful People in Business, and More

The year may be winding down, but Pfizer stayed busy on social media throughout November.CEO Albert Bourla celebrated the company’s fourth place ranking in the 2024 Access to Medicine Foundation Index—moving up two spots from the previous year—while Bourla himself was recognized in Fortune’s inaugural 100 Most Powerful People in Business. The CEO also proudly announced current Chief Oncology Officer Chris Boshoff’s ascension into the role of Chief Scientific Officer and President, R&D effective...

Why Real-World Learnings Matter for People with Breast Cancer

When people understand basic concepts about their health, they’re better able to make more informed decisions. That’s why we are working to improve health literacy, clarify the language that we use around health topics, and return clinical trials data to participants.A breast cancer diagnosis is life-changing; many people facing this diagnosis look to gather as much information about their prognosis and treatment options as possible. We know it’s not enough for us to simply develop breakthrough...

Pfizer Names Dr. Chris Boshoff Chief Scientific Officer

When the company you work for has been advancing breakthroughs for 175 years, there is a lot of scientific talent under one roof.We’re proud to announce that after a comprehensive search, Pfizer’s current Chief Oncology Officer and Executive Vice President, Dr. Chris Boshoff, M.D., Ph.D., has been appointed as Pfizer’s Chief Scientific Officer and President, Research & Development, effective January 1, 2025.Dr. Boshoff was selected after a comprehensive search that kicked off when Dr. Mikael...

Pfizer Works to Address Inequities in IBD Care

Despite advancements in technology that allow for broader reach and easier access to healthcare for people all over the globe, disparities in care remain a challenge, especially for women, diverse populations, and those in more rural areas. As we continue to work towards breakthroughs that change patients’ lives, we recognize that not all breakthroughs are medicine-related; we are also dedicated to improving equity and access for all patients around the world.Recently, we shared a series of...

2024 Health Equity in Action Summit: Communities Forward

Pfizer School of Science Mobile Experience: Inspiring the Next Generation of Innovators

In today's rapidly evolving world, scientific literacy and innovation are crucial for addressing global challenges and driving progress. Recognizing the importance of fostering a passion for science among young minds, Pfizer launched the Pfizer School of Science in its New York Headquarters — an innovative initiative aimed at inspiring and empowering the next generation of scientists and innovators.Bringing Science Education to Various Pfizer SitesThis year, we expanded outside the confines of...

Pfizer’s 4th Latino Summit Champions Latino Representation

In celebration of National Hispanic Heritage Month (September 15 through October 15 of 2024), Pfizer’s Latino Community Colleague Resource Group holds its annual Latino Summit. This year’s 4th annual Summit was held at Pfizer’s New York City headquarters on Wednesday, September 25th.The summit’s theme was "Deep Roots, Bold Vision” and was focused on speaking to the importance of the Latino community’s strong cultural foundation and forwarding-looking aspirations as professionals. Hosted by...

October Social Media Round-Up—Change the Odds, Forbes 2024 World’s Best Employers, and More

October was another eventful month here at Pfizer, and the evidence is all over our social media feeds.CEO Albert Bourla closed out October by celebrating Pfizer’s strong Q3 earnings report, but that wasn’t all the good news we shared. Bourla also shined a spotlight on our one billionth dose of pneumococcal vaccine, while his colleagues recognized the company’s inclusion in the Forbes’ 2024 list of World’s Best Employers, reflected on our partnerships with Patrick Dempsey and the American Cancer...

Working with Partners to Improve Access to Migraine Care

Migraine is a debilitating neurological disorder impacting over a billion people worldwide. At Pfizer, we’re dedicated to understanding the causes of migraine. With that goal in mind, we’ve put together a series of articles exploring different aspects of migraine management.In our first post, we looked at the current state of migraine care, reflecting on what’s working and where there’s room to improve. In the next post, we examined some of the challenges that can prevent people from accessing...

Migraine's Underrated Pain—The Barriers to Treatment

Migraine is a debilitating neurological disorder impacting over a billion people worldwide. At Pfizer, we’re dedicated to understanding the causes of migraine. With that goal in mind, we’ve put together a series of articles exploring different aspects of migraine management.In our first post, we looked at the current state of migraine care, reflecting on what’s working and where there’s room to improve. Then we examined some of the challenges that can prevent people from accessing the prescribed...